Colon-specific tablets containing 5-fluorouracil microsponges for colon cancer targeting

References

• Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134(5):1296–1310.
   PubMed Web of Science ®Google Scholar
• Rim SH, Seeff L, Ahmed F, et al. Colorectal cancer incidence in the United States, 1999-2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115(9):1967–1976.
   PubMed Web of Science ®Google Scholar
• Li S, Wang A, Jiang W, et al. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer. 2008;8(1):103.
   PubMedGoogle Scholar
• Abdellatif AAH, Zayed GM, Kamel HH, et al. A novel controlled release microsponges containing Albendazole against Haemonchus contortus in experimentally infected goats. J Drug Delivery Sci Technol. 2018;43:469–476.
   Web of Science ®Google Scholar
• Chickpetty SM, Raga B. Formulation, in vitro drug release and in vivo human X-ray investigation of polysaccharide based drug delivery systems for targeting 5-fluorouracil to the colon. Braz. J. Pharm. Sci. 2013;49(2):263–273.
   Web of Science ®Google Scholar
• Gupta S, Bedi P, Bedi N. Development and in vitro evaluation of Eudragit RS100 and Inulin coated pectin matrix tablets of 5-Fluorouracil for colon targeting. Int J of Applied Pharmaceutics. 2010;1(2):1–6.
   Google Scholar
• Sinha V, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharm Sci. 2003;18(1):3–18.
   PubMed Web of Science ®Google Scholar
• Rahman Z, Kohli K, Khar RK, et al. Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech. 2006;7(2):E113–E121.
   Web of Science ®Google Scholar
• Langenbach R, Danenberg P, Heidelberger C. Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate. Biochem Biophys Res Commun. 1972;48(6):1565–1571.
   PubMed Web of Science ®Google Scholar
• Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther. 1990;48(3):381–395.
   PubMed Web of Science ®Google Scholar
• Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. Aaps Pharmscitech. 2015;16(4):731–741.
   PubMed Web of Science ®Google Scholar
• Sinha V, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;224(1–2):19–38.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Lenourry A, Charrueau C, et al. The use of polysaccharides to target drugs to the colon. Carbohydr Polym. 2002;48(3):219–231.
   Web of Science ®Google Scholar
• Vemula SK, Veerareddy PR. Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Tech. 2009;1(1):1–35.
   Google Scholar
• Othman MH, Zayed GM, El Sokkary GH, et al. Preparation and evaluation of 5-fluorouracil loaded microsponges for treatment of colon cancer. J Cancer Sci Ther. 2017;09(01):307–313.
   Google Scholar
• Jelvehgari M, Siahi-Shadbad M, Azarmi S, et al. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm. 2006;308(1-2):124–132.
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell J, Attwood D, et al. An evaluation of pectin as a carrier for drug targeting to the colon. J Controlled Release. 1993;26(3):213–220.
   Web of Science ®Google Scholar
• Steed KP, Hooper G, Ventura P, et al. The in vivo behaviour of a colonic delivery system: a pilot study in man. Int J Pharm. 1994;112(3):199–206.
   Google Scholar
• Turkoglu M, Ugurlu T. In vitro evaluation of pectin–HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm. 2002;53(1):65–73.
   PubMed Web of Science ®Google Scholar
• Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm. 2006;318(1-2):103–117.
   PubMedGoogle Scholar
• Jain V, Jain D, Singh R. Factors effecting the morphology of eudragit S-100 based microsponges bearing dicyclomine for colonic delivery. J Pharm Sci. 2011;100(4):1545–1552.
   PubMed Web of Science ®Google Scholar
• May CD. Industrial pectins: sources, production and applications. Carbohydr Polym. 1990;12(1):79–99.
   Web of Science ®Google Scholar
• Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm. 2012;427(2):153–162.
   PubMedGoogle Scholar
• Vemula S, Veerareddy P. Formulation and evaluation of Ketorolac tromethamine tablets for time and pH dependent colon specific delivery. J Cur Pharm Res. 2011;8(1):31–39.
   Google Scholar
• Ofori-Kwakye K, Fell JT. Biphasic drug release: the permeability of films containing pectin, chitosan and HPMC. Int J Pharm. 2001;226(1-2):139–145.
   PubMed Web of Science ®Google Scholar
• Rizkalla CMZ, Latif Aziz R, Soliman II. In vitro and in vivo evaluation of hydroxyzine hydrochloride microsponges for topical delivery. AAPS PharmSciTech. 2011;12(3):989–1001.
   PubMed Web of Science ®Google Scholar
• Hassan WAA. Formulation and Evaluation of Drug loaded Microspheres for Potential Application [ph.D.Thesis]. Cairo: Al-Azhar University; 2011.
   Google Scholar
• Staniforth J. Powder flow In: Aulton’s Pharmaceutics: the design and manufacturing of medicines. Hungary: Harcourt publisher ltd; 2007.
   Google Scholar
• Martin A. Physical pharmacy: physical chemical principles in the pharmaceutical sciences. BI Waverly. Pvt Ltd; 1993.
   Google Scholar
• Devi SU, Thiruganesh R, Suresh S. Preparation and characterization of chitosan tablets of Aceclofenac for colon targeted drug delivery. Asian J Pharmaceu Res Health Care. 2010;2(1):46–65.
   Google Scholar
• Çomoğlu T, Gönül N, Baykara T. Preparation and in vitro evaluation of modified release ketoprofen microsponges. Farmaco. 2003;58(2):101–106.
   PubMedGoogle Scholar
• XXV UP. US Pharmacopoeia Convention. Rockville, MD. 2002. 2159–2160.
   Google Scholar
• Tuğcu-Demiröz F, Acartürk F, Takka S, et al. In-vitro and in-vivo evaluation of mesalazine–guar gum matrix tablets for colonic drug delivery. J Drug Target. 2004;12(2):105–112.
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y, Satyanarayana S, Prasad YR, et al. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J Control Release. 1998;55(2-3):245–252.
   PubMed Web of Science ®Google Scholar
• Zhao N, Augsburger LL. The influence of product brand-to-brand variability on superdisintegrant Performance. A case study with croscarmellose sodium. Pharm Dev Technol. 2006;11(2):179–185.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Ibrahim MA, Amin MA, et al. Cetuximab conjugated with octreotide and entrapped calcium alginate-beads for targeting somatostatin receptors. Sci Rep. 2020;10(1):4736.
   PubMed Web of Science ®Google Scholar
• Tawfeek HM, Abdellatif AAH, Dennison TJ, et al. Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets. Int J Pharm. 2017;531(1):80–89.
   PubMed Web of Science ®Google Scholar
• Mohammed HA, Al-Omar MS, El-Readi MZ, et al. Formulation of ethyl cellulose microparticles incorporated pheophytin a isolated from suaeda vermiculata for antioxidant and cytotoxic activities. Molecules. 2019;24(8):1501.
   Web of Science ®Google Scholar
• Abdellatif AAH. Identification of somatostatin receptors using labeled PEGylated octreotide, as an active internalization. Drug Dev Ind Pharm. 2019;45(10):1707–1715.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH. A plausible way for excretion of metal nanoparticles via active targeting. Drug Dev Ind Pharm. 2020;46(5):744–750.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Abou-Taleb HA, Abd El Ghany AA, et al. Targeting of somatostatin receptors expressed in blood cells using quantum dots coated with vapreotide. Saudi Pharm J. 2018;26(8):1162–1169.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Aldalaen SM, Faisal W, et al. Somatostatin receptors as a new active targeting sites for nanoparticles. Saudi Pharm J. 2018;26(7):1051–1059.
   PubMed Web of Science ®Google Scholar
• Tawfeek HM, Roberts M, El Hamd MA, et al. Glibenclamide mini-tablets with an enhanced pharmacokinetic and pharmacodynamic performance. AAPS PharmSciTech. 2018;19(7):2948–2960.
   PubMed Web of Science ®Google Scholar
• Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25(2):79–87.
   PubMedGoogle Scholar
• Kumari A, Jain A, Hurkat P, et al. Eudragit S100 coated microsponges for Colon targeting of prednisolone. Drug Dev Ind Pharm. 2018;44(6):902–913.
   PubMed Web of Science ®Google Scholar
• Gupta A, Tiwari G, Tiwari R, et al. Factorial designed 5-fluorouracil-loaded microsponges and calcium pectinate beads plugged in hydroxypropyl methylcellulose capsules for colorectal cancer. Int J Pharm Investig. 2015; 5(4):234–246.
   PubMed Web of Science ®Google Scholar
• Song Q, Jia J, Niu X, et al. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy. Nanoscale. 2019;11(34):15958–15970.
   PubMed Web of Science ®Google Scholar